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Metabolic ﬁngerprint after acute and under
sustained consumption of a functional beverage
based on grape skin extract in healthy human
subjects†
Olha Khymenets,a,b Cristina Andres-Lacueva,*a,b Mireia Urpi-Sarda,a,b
Rosa Vazquez-Fresno,a,b Mercè Mercader Mart,c Guillermo Reglero,b,d Mireia Torresc
and Rafael Llorach*a,b
Grape-derived polyphenols are considered to be one of the most promising ingredients for functional
foods due to their health-promoting activities. We applied a HPLC-MS-based untargeted metabolomic
approach in order to evaluate the impact of a functional food based on grape skin polyphenols on the
urinary metabolome of healthy subjects. Thirty-one volunteers participated in two dietary crossover ran-
domized intervention studies: with a single-dose intake (187 mL) and with a 15-day sustained consump-
tion (twice per day, 187 mL per day in total) of a functional beverage (FB). Postprandial (4-hour) and 24-
hour urine samples collected after acute consumption and on the last day of sustained FB consumption,
respectively, were analysed using an untargeted HPLC-qTOF-MS approach. Multivariate modelling with
subsequent application of an S-plot revealed diﬀerential mass features related to acute and prolonged
consumption of FB. More than half of the mass features were shared between the two types of samples,
among which several phase II metabolites of grape-derived polyphenols were identiﬁed at conﬁdence
level II. Prolonged consumption of FB was speciﬁcally reﬂected in urine metabolome by the presence of
ﬁrst-stage microbial metabolites of ﬂavanols: hydroxyvaleric acid and hydroxyvalerolactone derivatives.
Overall, several epicatechin and phenolic acid metabolites both of tissular and microbiota origin were the
most representative markers of FB consumption. To our knowledge, this is one of the ﬁrst studies where
an untargeted LC-MS metabolomic approach has been applied in nutrition research on a grape-
derived FB.
Introduction
Plant phytochemicals are considered to be one of the most
important health-promoting compounds present in our diet.1
Therefore, due to their strong bioactive potential, it is pro-
posed that phytochemical extracts from fruits and vegetables
serve as a principal component in a variety of nutraceuticals,
e.g. in functional foods.2 Over the recent decades, the concept
of functional food, food designed to allow consumers to eat
enriched foods close to their natural state,2 has attracted
much interest and popularity, since it was proposed as a novel
therapeutic approach to prevent or attenuate diet-related
diseases such as obesity, diabetes, atherosclerosis, and
neurodegeneration.3
Grape and grape-derived food products are well-known
sources of bioactive compounds, which are mainly represented
by a wide range of polyphenols, and, therefore, they are among
the most commonly used in the development of functional
foods.4,5 In general, grape and grape-derived products are
some of the most important natural sources of polyphenols in
our diet, and their dietary consumption is directly related to
various beneficial health eﬀects.6 Grape skin, being an edible
part of the berry, has an important antioxidant capacity due to
its high polyphenol content, among which the most abundant
are flavonoids, anthocyanins, proanthocyanidins, procyani-
dins, phenolic acids and stilbenes.6,7 Consequently, extracts
from grape skin are first-choice candidates for the develop-
†Electronic supplementary information (ESI) available. See DOI: 10.1039/
c4fo00684d
aBiomarkers and Nutrimetabolomic Lab., Department of Nutrition and Food Science,
XaRTA, INSA, Campus Torribera, Pharmacy School, University of Barcelona,
Barcelona, Spain. E-mail: rafallorach@ub.edu, candres@ub.edu;
Fax: +34 934035931; Tel: +34 934033798, +34 934034840
bINGENIO-CONSOLIDER Programme, Fun-C-Food CSD2007-063, Ministry of Science
and Innovation, Barcelona, Spain
cMiguel Torres, Vilafranca del Penedès, Barcelona, Spain
dInstituto de Investigación en Ciencias de la Alimentacion CIAL (CSIC-UAM),
Universidad Autonoma de Madrid, Madrid, Spain
1288 | Food Funct., 2015, 6, 1288–1298 This journal is © The Royal Society of Chemistry 2015
Pu
bl
ish
ed
 o
n 
19
 F
eb
ru
ar
y 
20
15
. D
ow
nl
oa
de
d 
by
 U
ni
ve
rs
ita
t d
e B
ar
ce
lo
na
 o
n 
08
/1
0/
20
15
 1
7:
39
:2
8.
 
View Article Online
View Journal  | View Issue
ment of functional foods and nutraceuticals to be used as an
alternative treatment in the management of several diet-
related diseases.4,5,8
Current progress in the development and implementation
of omics’ technologies has opened new perspectives in nutri-
tion research,9 e.g. food metabolome analysis,10 and, conse-
quently, they have become widely applied in nutraceutical
investigation.11 Today, metabolomics is being applied success-
fully in quality control,12 in metabolism evaluation13,14 and
also in the assessment of the beneficial eﬀects of functional
foods.11,15 In the latest perspective, untargeted metabolomics
is foreseen as one of the most promising approaches for
understanding the complex relationship between diet and
human health due to its potential for data-driven explora-
tion.16 Recently, in a couple of studies, an untargeted metabo-
lomic approach was applied in the evaluation of the impact of
grape-derived food and extract consumption on human
urinary metabolome using NMR technology alone17 or in com-
bination with GC-MS and LC-MS/MS approaches.14,18 The
results from these studies suggested that the metabolic fate of
grape-derived polyphenols and other bioactive compounds
could be clearly perceived by examining overall urinary meta-
bolome profiles.14,18,19 However, due to the limitations of the
NMR technical approach, mainly related to its relatively low
sensitivity (µmol–mmol range),20 just a few compounds could
be identified and related to the dietary consumption of grape-
derived products.14,17 Another methodological approach exten-
sively used in untargeted metabolomics, mass spectrometry
coupled with liquid chromatography (LC-MS), oﬀers highly
sensitive, reproducible and quasi-quantitative metabolite ana-
lyses.20,21 Therefore, this technique has become widely applied
in nutritional research.22 However, so far, no studies using
an LC-MS untargeted metabolomic approach have been per-
formed in human intervention studies with grape-derived pro-
ducts or functional foods.
The objective of the present study was to elucidate the
impact of acute and sustained consumption of a functional
beverage based on grape skin extracts on the urinary metabo-
lome (i.e. food metabolome) of healthy subjects by applying an
untargeted HPLC-MS metabolomic approach.
Experimental
Chemicals and reagents
The following chemicals were obtained commercially:
L-phenylalanine, 1-methyl-L-histidine, L-tryptophan, 20-deoxy-
guanosine, glycochenodeoxycholic acid, (−)-epicatechin and
procyanidin B2 (Sigma-Aldrich, St Louis, MO), 4-hydroxy-
hippuric acid (PhytoLab GmbH & Co., KG) and naringenin
(Extrasynthèse, Genay, France). HPLC-grade acetonitrile and
formic acid were purchased from Scharlau Chemie S.A. (Barce-
lona, Spain). Ultrapure water (Milli-Q) was obtained from a
Milli-Q Gradient A10 system (Millipore, Bedford, MA).
Human intervention study
Thirty-one healthy adult volunteers (15 men and 16 women,
aged 25–55 years) participated in a double-blind, placebo-con-
trolled, randomized crossover intervention study with a drink
containing grape skin extract. The study protocol was approved
by the Ethics Committee of the Hospital Universitario La Paz,
Madrid. The detailed study design was reported earlier.23
Briefly, one week prior to and during the 46 days of the study
the participants maintained a low-polyphenol diet. For the
acute study, after a seven-day washout period, the subjects con-
sumed 187 mL of the FB (functional beverage), containing a
grape skin extract, or the CB (control beverage), as a placebo,
in randomized order together with a standard breakfast con-
sisting of white bread, cheese and yoghurt. After that, they con-
sumed the corresponding beverage twice a day (at lunch and
dinner), 187 mL per day in total, for the next 15 days. The
same procedure was repeated after a second seven-day
washout period according to the crossover design.23 On the
last day of each washout and intervention period, 24-hour
urine samples were collected from volunteers. For the acute
study, urine samples collected during the first four postpran-
dial hours were used. All urine samples were stored in aliquots
at −80 °C prior to analysis.
Both the placebo (CB) and the intervention (FB) beverages
had the same macronutrient composition of carbohydrates
(sugars), 10 g L−1, and energy, 40 kcal L−1. The FB contained a
grape extract preparation obtained from red grape skins using
alcohol extraction under diﬀerent temperature conditions.
Therefore, due to the grape skin extract component, the FB
contained hydroxycinnamic (4280 µg L−1) and hydroxybenzoic
(83 mg L−1) acids, anthocyanins (16 mg L−1), flavanols (96 mg
L−1) and stilbenes (5.7 mg L−1), whereas the CB contained no
polyphenols.23 The FB had a total polyphenol index (I280) of
116 (arbitrary units), which is much higher than an average
wine index.24
LC-MS metabolomics analysis
The sample preparation was conducted according to a pre-
viously published methodology.25–27 HPLC-MS analysis was
performed using an Agilent 1200 Series Rapid Resolution
HPLC system coupled to a hybrid quadrupole TOF QSTAR Elite
(Applied Biosystems/MDS Sciex) according to the protocol
for untargeted metabolomic analysis established in our
group.25–27 Thus, chromatographic separation was performed
using a RP 18 Luna 5 µm, 50 × 2.0 mm column (Phenomenex,
Torrance, CA) in mobile phases consisted of (A) 0.1% HCOOH
and (B) ACN 0.1% HCOOH, at a flow rate of 600 µL min−1 with
the following linear gradient elution (t, %B): (0, 1), (4, 20),
(6, 95), (7.5, 95), (8, 1), (12, 1). q-TOF spray parameters were set
as previously described27 and full data acquisition was per-
formed in the scan range 70–700 m/z in positive ionization
mode. LC-MS data were acquired in three successive equili-
brated batches. In addition, samples and sequences of injec-
tions were randomized in order to avoid possible bias. Four
types of quality control (QC) were analysed along with samples
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in each batch in order to monitor the stability and functional-
ity of the system: QC1 – Milli-Q water; QC2 – 5 µg mL−1 of
exogenous standard mixture consisting of 4-hydroxyhippuric
acid, epicatechin, procyanidin B and naringenin; QC3 – 5 µg
mL−1 of endogenous standard mixture consisting of methyl-
L-histidine, deoxyguanosine, glycochenodeoxycholic acid,
phenylalanine and tryptophan; and QC4 – about 10% of all
samples were reinjected within the same batch. The QC data
were used in order to monitor the system’s stability and
functionality, guaranteeing the reliability of the acquired
data.25,27 Raw LC-MS data are deposited at the laboratory of
Biomarkers & Nutrimetabolomic Research Group, Nutrition &
Food Science Department, Pharmacy School, University of
Barcelona, and can be available upon request.
Data preprocessing
LC-MS raw data were processed using MarkerView™ 1.2.1 soft-
ware (Applied Biosystems, MDS Sciex, Toronto, Ontario,
Canada). Peak detection was performed using a minimum
spectral peak width of 1 ppm, a minimum RT peak width of
3 scans, a noise threshold of 5 and a subtraction multiple
factor of 1.5. The retention time tolerance was 0.1 min and the
mass tolerance was 0.05 Da.
Multivariate analysis (MVA) of data
The MVA was performed using SIMCA-P+ 13.0 software (Ume-
trics, Umea, Sweden). The data set was log-transformed and
Pareto-scaled before unsupervised principal component analy-
sis (PCA), and supervised statistical modelling by simple and
orthogonal partial least squares discriminant analysis (PLS-DA
and OPLS-DA, respectively). The PCA was used to gain an over-
view of the quality of the data acquisition step, while the
PLS-DAs were applied for the exploration of the diﬀerences in
metabolomes among the sample groups. OPLS separates the
system variation in X (LC-MS data) into two parts, one that is
linearly correlated (predictive) and one that is uncorrelated
(orthogonal) to Y. This separation facilitates the model
interpretation as the variation between classes that can be
interpreted from the predictive component, and the variation
within classes can be interpreted from the orthogonal com-
ponent.28 The type of beverage (CB vs. FB) and time of urine
collection (washout versus intervention) were used as categori-
cal Y variables in both the PLS-DA and OPLS-DA. The quality
of the supervised models was evaluated by the goodness-of-fit
parameter (R2X), the proportion of the variance of the response
variable that is explained by the model (R2Ycum) and the pre-
dictive ability parameter (Qcum
2), which was calculated by a
seven-round internal cross-validation of the data using a
default option of the SIMCA-P+ 13.0 software. The OPLS-DA
models were tested for overfitting with an ANOVA based on the
cross-validated predictive residuals (CV-ANOVA)29 using SIMCA
software, while the PLS-DA model was tested by the permu-
tation test (n = 200).30
Potential markers of interest were extracted from the S-plot,
a scatter plot that graphically combined the covariance and
correlation loading profiles resulting from the constructed
OPLS models.31 Pairwise discrimination between the FB and
CB classes for acute and sustained chronic consumption of
beverages was performed by two distinct S-plots and diﬀeren-
tial features were chosen based on their correlations in each
data set. Only mass features showing correlation coeﬃcients
(|p(corr)|) in both S-plots of ≥0.527 were included in the list of
candidate markers explaining the separation between FB and
CB interventions.
Metabolite identification
Markers contributing to the discrimination between diets were
identified through a multiple-step procedure.26,32 First, a two-
way hierarchical clustering analysis using the Pearson distance
and Ward’s method (PermutMatrix 1.9.3.0 software)33 was
applied to both sets of diﬀerential signals obtained from the
S-plots. Mass features and urine samples were clustered simul-
taneously in order to group the observations by their simi-
larities. The mass features corresponding to the same
metabolite – protonated molecules, 13C isotopes, adducts and
in-source generated fragments – were identified as clusters
based on a heat map of intensities and of a correlation
matrix.34 Second, identification of compounds was performed
on the basis of their exact mass (±5 mDa of accepted mass
diﬀerence), which was compared to those registered in an in-
house database35 that mainly focused on the food metabo-
lome, and in freely available external databases: the Human
Metabolome Database (HMDB; http://www.hmdb.ca) and the
MetLin database.36 In addition, the in-source fragmentation
behaviour of compounds, represented as ion clusters aggre-
gated by two-way HCA, was used as complementary infor-
mation to identify the metabolites.37 Finally, the metabolites
with the two highest levels of confidence identity, levels I and
II (when at least two orthogonal physicochemical properties,
such as mass, fragmentation or retention time, corresponded
with authentic standards or with public/in-house spectral
libraries, respectively),38 were taken into further consideration.
The biological relevance of the identified metabolites was eval-
uated based on information extracted from earlier published
reports accessed through free search engines.
Results
Data acquisition quality
PCA analysis of the three QC classes revealed a clear separation
between distinct control samples belonging to QC1, QC2 and
QC3 (Fig. 1S(A), ESI†). Neither carry-over nor apparent cluster-
ing due to the sequence of injections were detected. No artifi-
cial trends took place in the study samples during data
acquisition, since QC4 replicates were tightly clustered in the
PCA score plots (Fig. 1S(B), ESI†). The quality control results
were in agreement with criteria recently proposed for metabo-
lomics studies,25,27 suggesting that the overall quality of the
acquired data was good.
Paper Food & Function
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Analysis of urinary profiles in acute and midterm sustained
consumption studies
To assess the intervention-dependent changes in the urinary
metabolome in both consumption studies, an OPLS-DA using
two classes, FB and CB, was applied separately to the acute
and sustained studies’ data sets. The robust, high-quality 1 + 2
OPLS-DA models were obtained with regard to the separation
of samples by the type of beverage consumption for both
studies (Fig. 1A and B). Both OPLS-DA models were further
applied for metabolite discriminant analysis.
The metabolic profiles of 4-hour postprandial urine
samples and 24-hour urine samples collected on the last day
of the one-week washout and of the 15-day sustained interven-
tion periods were assessed using PLS-DA modelling. In con-
trast to both acute and sustained FB consumption, where
changes in urinary metabolic profiles were observed, no
important alterations in urinary metabolic profiles caused by
any intervention with the CB were noticed (Fig. 2S(A), ESI†).
The diﬀerences in 24-hour urinary metabolome between
washout and under sustained FB intervention were similar to
those observed in comparative analysis between the FB and CB
beverages (Fig. 2S(B), ESI†).
The S-plots31 associated with the OPLS-DA were generated
to reveal the statistically significant metabolites responsible
for FB consumption. The diﬀerential mass feature selection
using a reliability cut-oﬀ of p(corr) ≥ |0.5|, indicating a signifi-
cant relation to the consumption of the FB (upper-right quad-
rants) or CB (lower-left quadrants) beverages, is presented in
Fig. 2A and B, for acute and prolonged intervention studies,
respectively.
Comparative analysis of metabolome alteration due to acute
and sustained interventions
The comparison of metabolome modifications induced by
both acute and sustained FB intake was performed and aggre-
gation of m/z features are represented on a Venn diagram
(Fig. 3). The mass features positively aﬀected by FB intake
(p(corr) ≥ 0.5) were classified into three groups: specifically
related to acute consumption, specifically related to sustained
consumption, and a common group. In general, about 70% of
acute consumption markers were also detected in samples
from the sustained study, whereas 44% of markers were exclu-
sively related to the prolonged FB consumption in contrast to
about 30% for the acute consumption.
Fig. 2 S-plots associated with OPLS-DA score plots for data obtained from urine LC-MS analysis for acute (A) and sustained (B) intervention studies
on the consumption of both (FB and CB) beverages. Dashed lines represent p(corr) ≥ |0.5| cut-oﬀs used for the selection of putative markers
coloured in red and yellow for acute and sustained consumptions, respectively.
Fig. 1 Score plots of orthogonal partial least squares discriminant (OPLS-DA) modelling for acute (A) and 15-day sustained (B) intervention studies
with control (samples marked as blue and green cycles, respectively) and functional (samples marked as red and yellow cycles, respectively) bev-
erages. N – number of components in OPLS-DA modelling; O – orthogonal component; P – predictive component; R2Xcum and R
2Ycum are the
cumulative modelled variation in the X and Y matrix, respectively; Qcum
2 is the cumulative predicted variation in the Y matrix; the P-value from
CV-ANOVA, based on the cross-validated predictive residuals, is listed for both models (signiﬁcant result indicates a valid model).
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Characterization and identification of FB consumption
biomarkers
A number of diﬀerential compounds unique and common to
acute and sustained consumption studies detected as clusters
composed of diﬀerent kinds of ions were identified. Eighteen
metabolites, identified at least with confidence level II, are
summarized in Table 1 according to their main characteristics:
retention time, detected mass and postulated identification.
The identity of 4-hydroxyhippuric acid was confirmed compar-
ing its mass-chromatographic behaviour with the authentic
standard present in QC2 (Fig. 3S, ESI†). The rest of the meta-
bolites were annotated at confidence level II. All eighteen
metabolites from both studies had a higher relative abundance
in the samples related to the consumption of the FB. These
metabolites were considered in relation to their metabolic
origin: as host (represented principally by phase II metabolites
of polyphenols originally present in the grape skin) and
microbial (compounds derived from grape polyphenols due to
the catabolic activities of intestinal microbiota). With regard to
the diﬀerences in metabolic profiles observed between acute
and prolonged consumption of the FB, the sustained con-
sumption was clearly associated with the presence of meta-
bolites of an exclusively microbial origin.27 On the other hand,
only one postprandial-specific metabolite was identified,
while other metabolites were common for both sample types
(Table 1).
Discussion
The current study shows that acute and 15-day sustained con-
sumption of a FB based on grape skin extracts produces sig-
nificant changes in urinary metabolome. Using an LC-MS-
based untargeted approach with subsequent multivariate ana-
lysis, we identified a range of metabolites that are chiefly
related to the metabolism of grape skin polyphenols, a princi-
pal active component of the tested FB.
Metabolite 1 (Table 1) was annotated as tyrosine, based on
its LC-MS behaviour. It was the only discriminative metabolite
related specifically to acute intervention with an FB. This non-
essential amino acid was earlier also described as an impor-
tant contributor to the 6-hour postprandial urinary metabo-
lome changes provoked by acute consumption of cocoa
powder.27 According to the phytochemical database of Dr
Duke (http://www.ars-grin.gov/duke/plants.html), grape berries
can contain about 120–617 ppm of tyrosine. Therefore, it
could have been extracted along with other polyphenols and
consumed within the FB at much more elevated concen-
trations, thus appearing excreted in 4-hour postprandial urine.
Nevertheless, the endogenous origin of the detected tyrosine
must also be considered.
Elevated excretion of 4-hydroxyhippuric acid (Table 1,
metabolite 2) after consumption of the functional beverage
was noticed in both acute and under prolonged consumption
of FB. Recently, elevated 4-hydroxyhippurate was detected by
untargeted NMR, along with its 3-hydroxyl isoform, in 24-hour
urine samples after grape-derived product consumption.18
Consumption of other polyphenol-rich foods, such as tea39
and cocoa,40 was also related to its elevated excretion, which
was associated mainly with the microbial metabolism of con-
sumed proanthocyanidins and flavanols. On the other hand,
whether directly from the grape skin41 or released from pelar-
gonidin,42 4-hydroxybenzoic acid may directly undergo conju-
gation with glycine in the liver under its absorption in the
small intestine,43 forming 4-hydroxyhippuric acid. Thus, this
may explain its postprandial appearance after FB consump-
tion. Therefore, we relate 24-hour excretion of 4-hydroxyhippu-
ric acid under chronic consumption to both p-hydroxybenzoic
glycination and microbial catabolic activities.
Common to acute and sustained consumption of FB,
metabolites 3 and 6 (Table 1) were annotated as glucuronides
of hydroxy-dimethoxybenzoic acid based on their LC-MS be-
haviour. Their mass fragmentation patterns suggest to us that
they are conjugates of syringic and dimethylgallic acids,
however no specific assignment could be made due to the lack
of standards. Syringic acids could directly derive from the
grape extract due to their relative abundance in the berry
skin,44 or could originate in the body as microbiota catabolic
products45 derived from corresponding O-methylated flavonoid
syringetin and anthocyanidin malvidin, normally abundant in
red grapes.46 Therefore, syringic acid may be glucuroconju-
gated directly upon absorption or later after its release by
microbiota, and thus may be available in the body during the
first postprandial hours and over a prolonged time after inges-
tion. Earlier, syringic acid was reported to be elevated after sus-
tained consumption of grape-derived food.14,18,47 With regard
to dimethylgallic acid, very little information is available on
this metabolite in relation to polyphenol metabolism. Thus,
the 3,4-dimethyl derivative of gallic acid was proposed as a
putative marker of black tea consumption,48 in contrast to its
Fig. 3 Diagram showing the overlap among the m/z features and those
metabolites which were identiﬁed and annotated according to the levels
I and II of the conﬁdence of identity38 in both acute and sustained inter-
vention studies with functional beverage (FB). The corresponding listed
metabolites’ mass features are presented in Table 1.
Paper Food & Function
1292 | Food Funct., 2015, 6, 1288–1298 This journal is © The Royal Society of Chemistry 2015
Pu
bl
ish
ed
 o
n 
19
 F
eb
ru
ar
y 
20
15
. D
ow
nl
oa
de
d 
by
 U
ni
ve
rs
ita
t d
e B
ar
ce
lo
na
 o
n 
08
/1
0/
20
15
 1
7:
39
:2
8.
 
View Article Online
T
ab
le
1
M
e
ta
b
o
lit
e
s
w
h
ic
h
ar
e
p
o
si
ti
ve
ly
co
rr
e
la
te
d
w
it
h
ac
u
te
an
d
su
st
ai
n
e
d
co
n
su
m
p
ti
o
n
o
f
a
fu
n
ct
io
n
al
b
e
ve
ra
g
e
(F
B
)
M
et
ab
ol
it
e
cl
us
te
r
R
T
(m
in
)
D
et
ec
te
d
m
as
s
(m
/z
+
)
A
ss
ig
n
at
io
n
Id
en
ti
fi
ca
ti
on
E
le
m
en
ta
l
fo
rm
ul
a
Le
ve
la
of
id
en
ti
fi
ca
ti
on
B
io
lo
gi
ca
lr
el
ev
an
ce
to
in
te
rv
en
ti
on
A
cu
te
Su
st
ai
n
ed
1
0.
47
18
2.
08
33
[M
+
H
]+
Ty
ro
si
n
e
C
9
H
1
1
N
O
3
II
FB
or
en
do
ge
n
ou
sl
y
de
ri
ve
d
ty
ro
si
n
e
↑
—
2
2.
87
19
6.
05
98
[M
+
H
]+
4-
H
yd
ro
xy
h
ip
pu
ri
c
ac
id
C
9
H
9
N
O
4
I
H
yd
ro
xy
be
n
zo
ic
ac
id
an
d/
or
m
ic
ro
bi
al
po
ly
ph
en
ol
m
et
ab
ol
is
m
↑
↑
12
1.
02
74
[M
+
H
-G
ly
c]
+
12
2.
02
97
1
3
C
[M
+
H
-G
ly
c]
+
3
3.
15
39
2.
12
06
[M
+
N
H
4
]+
H
yd
ro
xy
-d
im
et
h
ox
yb
en
zo
ic
ac
id
gl
uc
ur
on
id
eb
C
1
5
H
1
8
O
1
1
II
H
yd
ro
xy
be
n
zo
ic
ac
id
an
d/
or
m
ic
ro
bi
al
po
ly
ph
en
ol
m
et
ab
ol
is
m
↑
↑
19
9.
06
18
[M
+
H
-G
lu
c]
+
15
5.
06
87
[M
+
H
-G
lu
c-
C
O
2
]+
4
3.
28
34
5.
08
33
[M
+
H
]+
Va
n
il
li
c
ac
id
gl
uc
ur
on
id
e
C
1
4
H
1
6
O
1
0
II
Ph
en
ol
ic
ac
id
an
d
po
ly
ph
en
ol
m
ic
ro
bi
al
m
et
ab
ol
is
m
↑
↑
36
2.
11
13
[M
+
N
H
4
]+
16
9.
04
99
[M
+
H
-G
lu
c]
+
12
5.
05
85
[M
+
H
-G
lu
c-
C
O
2
]+
5
3.
52
22
6.
07
27
[M
+
H
]+
Va
n
il
lo
yl
gl
yc
in
e
C
1
0
H
1
1
N
O
5
II
Ph
en
ol
ic
ac
id
an
d
po
ly
ph
en
ol
m
ic
ro
bi
al
m
et
ab
ol
is
m
↑
↑
22
7.
07
53
1
3
C
[M
+
H
]+
15
1.
04
2
[M
+
H
-G
ly
c]
+
12
3.
04
39
[M
+
H
-G
ly
c-
C
O
]+
6
3.
62
37
5.
09
73
[M
+
H
]+
H
yd
ro
xy
-d
im
et
h
ox
yb
en
zo
ic
ac
id
gl
uc
ur
on
id
eb
C
1
5
H
1
8
O
1
1
II
H
yd
ro
xy
be
n
zo
ic
ac
id
an
d/
or
m
ic
ro
bi
al
po
ly
ph
en
ol
m
et
ab
ol
is
m
↑
↑
39
2.
12
47
[M
+
N
H
4
]+
19
9.
06
24
[M
+
H
-G
lu
c]
+
15
5.
06
91
[M
+
H
-G
lu
c-
C
O
2
]+
14
0.
04
81
[M
+
H
-G
lu
c-
C
O
2
-
C
H
3
]+
7
3.
72
42
0.
15
01
[M
+
N
H
4
]+
4-
H
yd
ro
xy
-5
-(
di
h
yd
ro
xy
ph
en
yl
)-
va
le
ri
c
ac
id
gl
uc
ur
on
id
e
C
1
7
H
2
2
O
1
1
II
M
ic
ro
bi
al
m
et
ab
ol
is
m
of
fl
av
an
-3
-o
ls
—
↑
20
9.
08
1
[M
+
H
-G
lu
c-
H
2
O
]+
8
3.
88
40
3.
12
5
[M
+
H
]+
4-
H
yd
ro
xy
-5
-(
di
h
yd
ro
xy
ph
en
yl
)-
va
le
ri
c
ac
id
gl
uc
ur
on
id
e
C
1
7
H
2
2
O
1
1
II
M
ic
ro
bi
al
m
et
ab
ol
is
m
of
fl
av
an
-3
-o
ls
—
↑
42
0.
15
23
[M
+
N
H
4
]+
20
9.
08
12
[M
+
H
-G
lu
c-
H
2
O
]+
19
1.
07
06
[M
+
H
-G
lu
c-
H
2
O
-H
2
O
]+
14
9.
05
61
[M
+
H
-G
lu
c-
H
2
O
-H
2
O
-C
2
H
2
O
]+
9
4.
37
38
5.
11
51
[M
+
H
]+
5-
(D
ih
yd
ro
xy
ph
en
yl
)-
γ-
va
le
ro
la
ct
on
e
gl
uc
ur
on
id
e
C
1
7
H
2
0
O
1
0
II
M
ic
ro
bi
al
m
et
ab
ol
is
m
of
fl
av
an
-3
-o
ls
—
↑
40
7.
09
59
[M
+
N
a]
+
40
2.
14
01
[M
+
N
H
4
]+
40
3.
14
44
1
3
C
[M
+
N
H
4
]+
20
9.
08
19
[M
+
H
-G
lu
c]
+
21
0.
08
39
1
3
C
[M
+
H
-G
lu
c]
+
19
1.
07
07
[M
+
H
-G
lu
c-
H
2
O
]+
10
4.
57
38
5.
11
3
[M
+
H
]+
5-
(D
ih
yd
ro
xy
ph
en
yl
)-
γ-
va
le
ro
la
ct
on
e
gl
uc
ur
on
id
e
C
1
7
H
2
0
O
1
0
II
M
ic
ro
bi
al
m
et
ab
ol
is
m
of
fl
av
an
-3
-o
ls
—
↑
38
6.
11
53
1
3
C
[M
+
H
]+
40
7.
09
27
[M
+
N
a]
+
40
2.
13
82
[M
+
N
H
4
]+
40
3.
14
03
1
3
C
[M
+
N
H
4
]+
36
7.
10
09
[M
+
H
-H
2
O
]+
20
9.
08
13
[M
+
H
-G
lu
c]
+
21
0.
08
3
1
3
C
[M
+
H
-G
lu
c]
+
19
1.
06
98
[M
+
H
-G
lu
c-
H
2
O
]+
19
2.
07
23
1
3
C
[M
+
H
-G
lu
c-
H
2
O
]+
Food & Function Paper
This journal is © The Royal Society of Chemistry 2015 Food Funct., 2015, 6, 1288–1298 | 1293
Pu
bl
ish
ed
 o
n 
19
 F
eb
ru
ar
y 
20
15
. D
ow
nl
oa
de
d 
by
 U
ni
ve
rs
ita
t d
e B
ar
ce
lo
na
 o
n 
08
/1
0/
20
15
 1
7:
39
:2
8.
 
View Article Online
T
ab
le
1
(C
o
n
td
.)
M
et
ab
ol
it
e
cl
us
te
r
R
T
(m
in
)
D
et
ec
te
d
m
as
s
(m
/z
+
)
A
ss
ig
n
at
io
n
Id
en
ti
fi
ca
ti
on
E
le
m
en
ta
l
fo
rm
ul
a
Le
ve
la
of
id
en
ti
fi
ca
ti
on
B
io
lo
gi
ca
lr
el
ev
an
ce
to
in
te
rv
en
ti
on
A
cu
te
Su
st
ai
n
ed
14
9.
05
81
[M
+
H
-G
lu
c-
C
2
H
3
O
2
]+
13
1.
04
68
[M
+
H
-G
lu
c-
C
2
H
3
O
2
-
H
2
O
]+
12
3.
04
16
[M
+
H
-G
lu
c-
C
2
H
3
O
2
-
C
2
H
2
]+
11
4.
67
46
7.
11
65
[M
+
H
]+
(e
pi
)C
at
ec
h
in
gl
uc
ur
on
id
ec
C
2
1
H
2
2
O
1
2
II
E
pi
ca
te
ch
in
m
et
ab
ol
is
m
↑
↑
29
1.
08
94
[M
+
H
-G
lu
c]
+
13
9.
03
93
[M
+
H
-G
lu
c-
C
8
H
8
O
3
c
]+
12
4.
73
39
9.
13
25
[M
+
H
]+
5-
(H
yd
ro
xy
-m
et
h
ox
y-
ph
en
yl
)-
γ-
va
le
ro
la
ct
on
e
gl
uc
ur
on
id
e
C
1
8
H
2
2
O
1
0
II
M
ic
ro
bi
al
m
et
ab
ol
is
m
of
fl
av
an
-3
-o
ls
—
↑
41
6.
15
9
[M
+
N
H
4
]+
41
7.
16
13
1
3
C
[M
+
N
H
4
]+
22
3.
09
82
[M
+
H
-G
lu
c]
+
22
4.
10
04
1
3
C
[M
+
H
-G
lu
c]
+
20
5.
08
7
[M
+
H
-G
lu
c-
H
2
O
]+
16
3.
07
56
[M
+
H
-G
lu
c-
H
2
O
-C
2
H
2
O
]+
13
4.
85
36
9.
11
95
[M
+
H
]+
5-
(H
yd
ro
xy
ph
en
yl
)-
γ-
va
le
ro
la
ct
on
e
gl
uc
ur
on
id
e
C
1
7
H
2
0
O
9
II
M
ic
ro
bi
al
m
et
ab
ol
is
m
of
fl
av
an
-3
-o
ls
—
↑
37
0.
12
29
1
3
C
[M
+
H
]+
35
1.
10
92
[M
+
H
-H
2
O
]+
19
3.
08
67
[M
+
H
-G
lu
c]
+
19
4.
08
95
1
3
C
[M
+
H
-G
lu
c]
+
13
3.
06
41
[M
+
H
-G
lu
c-
C
2
H
3
O
2
]+
14
5
30
7.
05
13
[M
+
H
]+
4-
H
yd
ro
xy
-5
-(
di
h
yd
ro
xy
ph
en
yl
)-
va
le
ri
c
ac
id
su
lp
h
at
e
C
1
1
H
1
4
O
8
S
II
M
ic
ro
bi
al
m
et
ab
ol
is
m
of
fl
av
an
-3
-o
ls
—
↑
28
9.
03
79
[M
+
H
-H
2
O
]+
15
5.
17
22
3.
09
5
[M
+
H
-G
lu
c]
+
5′
-(
H
yd
ro
xy
-m
et
h
ox
y-
ph
en
yl
)-
γ-
va
le
ro
la
ct
on
e
gl
uc
ur
on
id
e
C
1
2
H
1
4
O
4
II
M
ic
ro
bi
al
m
et
ab
ol
is
m
of
fl
av
an
-3
-o
ls
—
↑
16
5.
45
37
1.
04
3
[M
+
H
]+
(e
pi
)C
at
ec
h
in
su
lp
h
at
e-
2
C
1
5
H
1
4
O
9
S
II
E
pi
ca
te
ch
in
m
et
ab
ol
is
m
↑
↑
17
5.
9
37
1.
04
45
[M
+
H
]+
(e
pi
)C
at
ec
h
in
su
lp
h
at
e-
3
C
1
5
H
1
4
O
9
S
II
E
pi
ca
te
ch
in
m
et
ab
ol
is
m
↑
↑
18
6.
03
42
0.
14
93
[M
+
N
H
4
]+
D
ih
yd
ro
si
n
ap
ic
ac
id
gl
uc
ur
on
id
e
C
1
7
H
2
2
O
1
1
II
Ph
en
ol
ic
ac
id
an
d
po
ly
ph
en
ol
m
ic
ro
bi
al
m
et
ab
ol
is
m
↑
↑
22
7.
09
04
[M
+
H
-G
lu
c]
+
22
8.
09
37
1
3
C
[M
+
H
-G
lu
c]
+
15
5.
07
09
[M
+
H
-G
lu
c-
C
2
H
4
C
O
O
]+
14
0.
04
71
[M
+
H
-G
lu
c-
C
2
H
4
C
O
O
-C
H
3
]+
G
lu
c
–
gl
uc
ur
on
id
e
re
si
du
e;
G
ly
c
–
gl
yc
in
e
re
si
du
e.
a
Le
ve
ls
of
id
en
ti
fi
ca
ti
on
ar
e
re
po
rt
ed
ac
co
rd
in
g
to
Su
m
n
er
et
al
.3
8
(2
00
7)
.
b
E
it
h
er
sy
ri
n
gi
c
or
di
m
et
h
yl
ga
lli
c
ac
id
gl
uc
ur
on
id
e,
n
o
sp
ec
if
ic
as
si
gn
m
en
t
co
ul
d
be
m
ad
e
du
e
to
th
e
la
ck
of
st
an
da
rd
s.
c
Fr
ag
m
en
t
of
(e
pi
)c
at
ec
h
in
,
ac
co
rd
in
g
to
Fl
am
in
i
R
.6
1
↑
in
di
ca
te
s
h
ig
h
er
le
ve
ls
af
te
r
FB
co
n
su
m
pt
io
n
in
co
m
pa
ri
so
n
to
C
B
co
n
su
m
pt
io
n
(p
[c
or
r]
≤
0.
05
);
—
,n
o
ch
an
ge
s
w
er
e
ob
se
rv
ed
.
Paper Food & Function
1294 | Food Funct., 2015, 6, 1288–1298 This journal is © The Royal Society of Chemistry 2015
Pu
bl
ish
ed
 o
n 
19
 F
eb
ru
ar
y 
20
15
. D
ow
nl
oa
de
d 
by
 U
ni
ve
rs
ita
t d
e B
ar
ce
lo
na
 o
n 
08
/1
0/
20
15
 1
7:
39
:2
8.
 
View Article Online
3,5-dimethyl isoform (syringic acid), suggesting that the two
isomers detected in our samples could originate from diﬀerent
ways. However, both of them might also have a common origin
related to 3-O-methylated gallic acid,48,49 originating from the
corresponding anthocyanin, petunidin, abundant in grape
skin46 or as a minor O-methylated metabolite49 of grape-
derived gallic acid. However, due to the limited information
available, it is diﬃcult to be conclusive with certainty about
the origins of dimethylgallic acid with respect to our
intervention.
Metabolites 4 and 5 (Table 1), positively changed in both
postprandial and after prolonged FB consumption urine
samples, were annotated as vanillic acid glucuronide and
vanilloylglycine, respectively, based on their LC-MS character-
istics. Recently, vanilloylglycine was detected in 24-hour urine
samples after regular dealcoholized red wine consumption.47
Both compounds were related to the colonic microbiota
metabolism of dietary polyphenols, principally of hydroxycin-
namates50,51 and flavan-3-ols,27,52 also quite abundant in
grape berry skins.44 However, in our study we have already
detected these metabolites in 4-hour postprandial urine
samples. This could be explained by the fact that vanillic acid
was probably already present in the FB polyphenol extract, as
was shown for red grape skin.44 Thus, we hypothesize that on
the one hand, both metabolites could be directly related to the
FB polyphenol extract, and on the other, they could be related
to the microbial metabolism of more complex grape skin poly-
phenols, therefore being excreted as glucuronidated and glyci-
nated derivatives of vanillic acid in urine samples obtained
both after acute and sustained consumption.
Metabolite 18 (Table 1), common to both acute and sus-
tained FB consumption, was annotated as dihydrosinapic acid
glucuronide according to its LC-MS behaviour. It is a meta-
bolite of sinapic acid via reduction of the double bond in the
cinnamic acid side chain.50,51 Sinapic acid is among the most
abundant hydroxycinnamates found in red grapes and derived
products,53 and recently its increase in 24-hour urine samples
was related to consumption of dealcoholized red wine.47
However, no data on the detection of its hydrated metabolite,
dihydrosinapic acid, in relation to dietary consumption of
polyphenols, have been reported yet. Recently, it was proposed
that reduction activity on cinnamates is not restricted only to
intestinal microflora activity, as tissular metabolism54 might
also be involved. Therefore, we postulated that dihydrosinapic
acid detected in acute samples might also be generated as a
phase I metabolite of sinapic acid, and later, upon prolonged
ingestion of an FB, appear in urine as a microbial metabolite
as well.
Metabolites 11, 16 and 17 (Table 1) were annotated as a glu-
curonide and two sulphates of epicatechin, respectively, based
on their LC-MS behaviour. The increase of epicatechin in
urinary host metabolites during both acute and sustained con-
sumption of FB, was obviously related to the intake of flavan-3-
ols, which are the most abundant class of flavonoids present
in grape and related products.46,53 In general, epicatechin
phase II metabolites are recognized markers of consumption
of flavanol-rich food,26,27,55,56 especially for postprandial
stages. Their relation to the consumption of grape and derived
food products was recently reported by our group in a targeted
metabolomics study on the consumption of dealcoholized
wine.47 Relatively short excretion times of epicatechin phase II
metabolites enable their identification in both of our sample
types: 4-hour postprandial and 24-hour urine samples. In con-
trast, the metabolites 7, 8, 14 and metabolites 9, 10, 12, 15 and
13 (Table 1) were identified as principal discriminant meta-
bolites of prolonged FB consumption. Based on their exact
masses, retention times and in-source fragmentation patterns,
these compounds were annotated as belonging to first-stage
flavan-3-ol microbial metabolism57 derivatives of hydroxy-
(dihydroxyphenyl)-valeric acid (two glucuronides and sul-
phate), and derivatives of dihydroxyphenyl- (two glucuronides),
hydroxy-methoxyphenyl- (two glucuronides) and hydroxyphe-
nyl-valerolactones (one glucuronide), respectively. Earlier,
various phase II hydroxyvaleric acid and hydroxyvalerolactone
derivatives, including those identified in the present study,
were also reported to be markers of consumption of flavanol-
rich food such as almond skin,55 cocoa26,27 and tea.52,58
Although grapes, especially red ones, are known to be very rich
in flavanols, so far no studies have reported on their
microbial metabolites in relation to grape polyphenol con-
sumption. Only recently, our group suggested them as markers
of chronic grape-derived product consumption (dealcoholized
red wine) using targeted LC-MS analysis,47 and the
present study, applying an untargeted approach, has
ratified that the phase II metabolites of microbiota-derived
hydroxyvaleric acid and hydroxyvalerolactones could serve
as principal markers of prolonged grape skin flavanol
consumption.
Similarities between urinary metabolome under acute and
prolonged intakes of grape skin polyphenols, both as diﬀeren-
tial mass features (Fig. 2) and identified metabolites (Table 1),
were observed. This is in line with the notion that the urine
under sustained consumption should also contain compounds
related to postprandial metabolism, since the 24-hour urine
samples were collected on the last intervention day when the
last two doses of the FB had been consumed at lunch and
dinner. Diﬀerences in the metabolic profiles of the continuous
consumption were clearly associated with the presence of
metabolites of an exclusively microbial origin (Table 1).
According to the study design and analysis, all unique mass
features detected under sustained consumption, including un-
identified ones, should be related either directly to microbial
metabolism or to eﬀects provoked by prolonged grape skin
polyphenol consumption.
In contrast to prolonged consumption, we identified only
one postprandial-specific metabolite. As we explained earlier,
we expected mass features unique to the 4-hour postprandial
sample also to be present in 24-hour urine samples, however
they could not be detected due to the metabolome-diluting
eﬀect. Thus, in this study the acute samples were used for two
purposes: (i) to evaluate 4-hour postprandial urinary metabo-
lome after FB intake; and (ii) to contrast those metabolites
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related specifically to 24-hour urine under prolonged grape
skin consumption.
The potential health eﬀects of grape polyphenols are of par-
ticular interest from the nutraceutical and functional food
viewpoints.4,5,7,8 The mechanisms by which grape polyphenols
exert their protective eﬀects are not entirely clear, but they are
conditioned by polyphenol bioavailability within the human
organism.53 The detection of polyphenol metabolites in urine
following their dietary ingestion approximates their availability
and recapitulates their fate in an organism, linking it to their
biological eﬀects. Previously, such evaluations were usually
studied applying (targeted) analysis that was specifically
focused on the main polyphenols or on grape-specific polyphe-
nols.23,47,59,60 Thus, our previous study characterized in detail
the resveratrol metabolism following ingestion of the func-
tional beverage tested in the present study by applying a tar-
geted LC-MS approach.23 Since, the resveratrol metabolites
could not be detected in the present study, probably due to the
technical limitation of the applied untargeted approach, the
results of the targeted study could be considered as comp-
lementary data to our results, confirming the bioavailability of
ingested polyphenols. Our study, applying an untargeted
LC-MS approach and data-driven analysis, was able to show
that after dietary ingestion of grape skin polyphenols in the
form of a functional beverage, the main alterations in urinary
metabolites were related to polyphenol metabolism. As a
result, we were able to assess the specificity of these alterations
under sustained consumption with respect to the postprandial
period.
Conclusion
In conclusion, our study showed that single and prolonged
consumption of a grape skin polyphenol-based FB promoted
significant changes in the profiles of urinary low-weight
metabolites. To our knowledge, this is the first study to assess
the urinary metabolic fingerprint of dietary ingested grape
polyphenols applying an untargeted LC-MS approach.
Although our study was performed with a limited (for un-
targeted metabolomics) number of subjects living within close
geographical area, the application of the crossover study
design and highly sensitive HPLC-qTOF-MS technology
enabled us to detect that the principal changes in urinary
metabolome were related to the grape skin polyphenol meta-
bolism. Thus, on the one hand, various metabolites of grape
skin-derived phenolic acids and epicatechins were mutually
identified in 4-hour postprandial and 24-hour urine samples
after acute and under prolonged sustained consumption of FB,
respectively. These metabolites could be recognized as generic
markers of grape skin polyphenol consumption. On the other
hand, several first-stage microbial metabolites represented by
the phase II metabolites of hydroxyvaleric acid and hydroxy-
valerolactone derivatives were also associated with high grape
skin flavanol content. They were exclusively present in 24-hour
urine samples during sustained consumption of the FB, there-
fore we would suggest them as principal microbiota-derived
markers of prolonged consumption of grape skin polyphenols.
However, it should be mentioned that despite the controlled
dietary conditions, which were applied in the present study,
these metabolites cannot be considered solely as biomarkers
of grape skin polyphenol intake since most of them have also
been identified after consumption of other sources of flavan-
3-ols, such as cocoa, almond,26,27,55 and tea.58 Furthermore,
we should admit that the use of only positive ionization con-
ditioned our research to discover principally positively ionized
markers. This should be reconsidered in future studies, since
negative ionization could provide complementary metabolic
data. In addition, a multimetabolite marker approach recently
introduced in nutrimetabolomics32 could provide more accu-
rate evaluation of the exposure to grape-derived polyphenols,
but this should be specifically tested. Therefore, we would
suggest that the health impact of the tested functional bever-
age consumption, as well as other foods with grape skin-
derived components, should be studied considering the com-
plexity of polyphenol metabolism.
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